Warning: The NCBI web site requires JavaScript to function. more...
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation.
Busso N, Chobaz-Péclat V, Hamilton J, Spee P, Wagtmann N, So A.
Arthritis Res Ther. 2008;10(2):R42. Epub 2008 Apr 15.
Related citations
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.
Pawlinski R, Pedersen B, Schabbauer G, Tencati M, Holscher T, Boisvert W, Andrade-Gordon P, Frank RD, Mackman N.
Blood. 2004 Feb 15;103(4):1342-7. Epub 2003 Oct 23.
Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.
Pawlinski R, Mackman N.
Crit Care Med. 2004 May;32(5 Suppl):S293-7. Review.
Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.
Strukova S.
Front Biosci. 2006 Jan 1;11:59-80. Review.
Role of the tissue factor pathway in synovial inflammation.
Busso N, Morard C, Salvi R, Péclat V, So A.
Arthritis Rheum. 2003 Mar;48(3):651-9.
Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit.
Chu AJ.
Front Biosci. 2006 Jan 1;11:256-71. Review.
Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
Fan L, Yotov WV, Zhu T, Esmailzadeh L, Joyal JS, Sennlaub F, Heveker N, Chemtob S, Rivard GE.
J Thromb Haemost. 2005 May;3(5):1056-63.
Protease-activated receptor 2 blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure.
Jesmin S, Gando S, Zaedi S, Prodhan SH, Sawamura A, Miyauchi T, Hiroe M, Yamaguchi N.
Shock. 2009 Dec;32(6):626-32.
Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation.
Saban R, Simpson C, Davis CA, Dozmorov I, Maier J, Fowler B, Ihnat MA, Hurst RE, Wershil BK, Saban MR.
BMC Immunol. 2007 Aug 17;8:17.
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.
Luyendyk JP, Sullivan BP, Guo GL, Wang R.
Am J Pathol. 2010 Jan;176(1):177-86. Epub 2009 Dec 11.
Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1.
Ahamed J, Belting M, Ruf W.
Blood. 2005 Mar 15;105(6):2384-91. Epub 2004 Nov 18.
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury.
Sevastos J, Kennedy SE, Davis DR, Sam M, Peake PW, Charlesworth JA, Mackman N, Erlich JH.
Blood. 2007 Jan 15;109(2):577-83. Epub 2006 Sep 21.
Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
Jesmin S, Gando S, Zaedi S, Sakuraya F.
Thromb Haemost. 2006 Dec;96(6):830-8.
Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.
Luyendyk JP, Mackman N, Sullivan BP.
Toxicol Sci. 2011 Jan;119(1):233-43. Epub 2010 Oct 25.
Roles of protease-activated receptors in a mouse model of endotoxemia.
Camerer E, Cornelissen I, Kataoka H, Duong DN, Zheng YW, Coughlin SR.
Blood. 2006 May 15;107(10):3912-21. Epub 2006 Jan 24.
PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.
Zhang JJ, Kelm RJ, Biswas P, Kashgarian M, Madri JA.
J Cell Physiol. 2007 Feb;210(2):527-37.
Tissue factor mediates inflammation.
Arch Biochem Biophys. 2005 Aug 15;440(2):123-32. Review.
The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury.
Mackman N.
Semin Vasc Med. 2003 May;3(2):193-8. Review.
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
Weijer S, Schoenmakers SH, Florquin S, Levi M, Vlasuk GP, Rote WE, Reitsma PH, Spek CA, van der Poll T.
J Infect Dis. 2004 Jun 15;189(12):2308-17. Epub 2004 May 25.
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW, Weijer S, Bresser P, Florquin S, Vlasuk GP, Rote WE, Spek CA, Reitsma PH, van der Zee JS, Levi M, van der Poll T.
Crit Care Med. 2006 Jun;34(6):1725-30.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on